Sernova Corp T.SVA

DF - Post 30879236???

[jwallisca]

DF:

Your post 30879236 is anything but clear of what you mean, or are trying to say.

Firstly, which Board are you talking about, the Stockhouse "Board", or Sernova's "Board". If you mean the latter, you will never get an answer to what you are asking from any company. If you mean this Stockhouse BB, it is 100% NOT material.

I am assuming you mean Sernova's Board of directors.

IF you believe a company's Board does supply the kind of answers you are seeking, please supply examples, especially juniors and in particular junior pharmaceuticals.

In case you don't know it, developing a pharmaceutical product, testing it to see whether it works safely, then testing it for use in humans and then taking it to the marketing stage is not done in a few years. A decade, or more, is often required. Sernova's Pouch is now in the final stages of being verified for use by people. Can you not wait a few more months?

Despite opinions to the contrary by pundits on this BB, the speed that Sernova got The Pouch approved for this FDA trial is nothing short of astounding. Typically, many applications for an FDA trial are rejected. Many others require multiple applications before getting the green light to proceed. Further, very few juniors get approval from the FDA to do a trial.

Sernova was approved the very first try and in a short, timely period. This happened because it knew exactly what was required. CTI combined with the knowledgeable and tireless efforts of Dr. Toleikis got it done and in Warp Speed to use a Star Trek analogy.

Having an FDA trial for a disruptive medicine product, by a junior pharmaceutical like Sernova, is unbelievable business development. In case readers don't know, an FDA trial for a pharmaceutical product is The Gold Standard for verification... Sernova's results given publicly to date demonstrate The Pouch will be a product that will be used by people. How much better business devlopment does one want?

Regarding business development, what are you looking for from a tiny, penny junior? Please give some indications of what you believe would be good business development by Sernova.

Your vague questions and expectations are completely out of touch with what a company like Sernova can, or should provide.

Regarding the Board, please see their experience starting P8. Please note that James T. Parsons is currently Chief Financial Officer of Trillium Therapeutics Inc., a Nasdaq-listed biotechnology company, since August 2011. "TRIL" is one company where the share price languished until it did not. Trillium has much less to offer than The Pouch.
https://sernova.com/pdf/agm/Circular2020.pdf

I reiterate, shareholders please vote and please support management. Despite opinions to the contrary, Sernova has accomplished much. Is this reflected in the share price? No, not yet. I reiterate that BLU and TRIL are two such examples where share price and development didn't track progress until they did and in a step function manner.

jwall